广州再生医学与健康广东省实验室-官网
广州再生医学与健康广东省实验室-官网
论文
首页 >> 科学研究 >> 科研产出 >> 论文
论文题目 刊物名称 影响因子 发表时间
Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer Acta Pharmacologica Sinica 3.562 2019年5月
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer Journal of medicinal chemistry 6.253 2019年5月
Expanded targeting scope and enhanced base editing efficiency in rabbit using optimized xCas9(3.7) Cellular and Molecular Life Sciences 6.721 2019年4月
Optimal Antithrombotic Therapy for Patients with STEMI Undergoing PCI at High Risk of Bleeding Current Atherosclerosis Reports 2.56 2019年4月
Plasmodium infection inhibits the expansion and activation of MDSCs and Tregs in the tumor microenvironment in a murine Lewis lung cancer model Cell Communication and Signaling: CCS 5.324 2019年4月
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints Leukemia 10.023 2019年4月
Discovery and Biosynthesis of Atrovimycin, an Antitubercular and Antifungal Cyclodepsipeptide Featuring Vicinal-dihydroxylated Cinnamic Acyl Chain Organic Letters 6.492 2019年4月
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis Nature communications 12.353 2019年4月
Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome Kidney Int 8.429 2019年4月